SCHEDULE 13G/A: Rubric Capital Management Discloses 3.67% Passive Stake in Pediatrix Medical Group
Beneficial Ownership Report
Rubric Capital Management LP and David Rosen have reported a 3.67% beneficial ownership stake in Pediatrix Medical Group, Inc. as of December 31, 2024, held for investment purposes.
Summary
- Rubric Capital Management LP and David Rosen, collectively referred to as the Reporting Persons, have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in Pediatrix Medical Group, Inc.
- As of December 31, 2024, the Reporting Persons beneficially own an aggregate of 3,148,440 shares of Pediatrix Medical Group, Inc. Common Stock.
- This ownership represents 3.67% of the Issuer's outstanding Common Stock.
- The percentage is calculated based on 85,880,487 shares of Common Stock outstanding as of October 25, 2024, as reported in the Issuer's Form 10-Q.
- Rubric Capital Management LP, a Delaware limited partnership, acts as an investment adviser to certain investment funds and/or accounts holding the shares.
- David Rosen, a U.S. citizen, is the Managing Member of Rubric Capital Management GP LLC, the general partner of Rubric Capital.
- The shares are held in the ordinary course of business and not for the purpose of changing or influencing the control of the Issuer, consistent with a passive investment strategy.
Sentiment
Score: 5
Explanation: The document is a routine Schedule 13G amendment disclosing a passive beneficial ownership stake, which does not inherently convey positive or negative sentiment regarding the issuer's operational performance or future prospects. It is a factual disclosure of ownership.
Positives
- Rubric Capital Management LP, an investment adviser, and David Rosen, its managing member, hold a significant stake, indicating their investment in the company.
Negatives
- None directly related to company performance or operations are disclosed in this ownership filing.
Risks
- None mentioned in this beneficial ownership disclosure, as it pertains solely to the reporting of a passive investment stake.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's stake in the company.
Next Steps
- No specific future actions or milestones are mentioned by the reporting persons or the issuer in this filing.
Key Dates
| Date | Description |
|---|---|
| 2024-10-25 | Date as of which 85,880,487 shares of Common Stock were outstanding, used for percentage calculation. |
| 2024-12-31 | Date of event which requires the filing of this statement. |
| 2025-02-13 | Date the Schedule 13G Amendment No. 1 was signed and filed. |
Keywords
Pediatrix Medical Group, Rubric Capital Management, David Rosen, Beneficial Ownership, SEC Filing, Schedule 13G, Common Stock, Healthcare Investment, Passive Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.